Literature DB >> 29610140

Mycobacterium tuberculosis Transfer RNA Induces IL-12p70 via Synergistic Activation of Pattern Recognition Receptors within a Cell Network.

Caroline Keegan1,2, Stephan Krutzik1, Mirjam Schenk1, Philip O Scumpia1, Jing Lu3, Yan Ling Joy Pang4, Brandon S Russell4, Kok Seong Lim4, Scarlet Shell5, Erin Prestwich4, Dan Su4, David Elashoff6, Robert M Hershberg7, Barry R Bloom5, John T Belisle8, Sarah Fortune5, Peter C Dedon4,9, Matteo Pellegrini1,3, Robert L Modlin10,2.   

Abstract

Upon recognition of a microbial pathogen, the innate and adaptive immune systems are linked to generate a cell-mediated immune response against the foreign invader. The culture filtrate of Mycobacterium tuberculosis contains ligands, such as M. tuberculosis tRNA, that activate the innate immune response and secreted Ags recognized by T cells to drive adaptive immune responses. In this study, bioinformatics analysis of gene-expression profiles derived from human PBMCs treated with distinct microbial ligands identified a mycobacterial tRNA-induced innate immune network resulting in the robust production of IL-12p70, a cytokine required to instruct an adaptive Th1 response for host defense against intracellular bacteria. As validated by functional studies, this pathway contained a feed-forward loop, whereby the early production of IL-18, type I IFNs, and IL-12p70 primed NK cells to respond to IL-18 and produce IFN-γ, enhancing further production of IL-12p70. Mechanistically, tRNA activates TLR3 and TLR8, and this synergistic induction of IL-12p70 was recapitulated by the addition of a specific TLR8 agonist with a TLR3 ligand to PBMCs. These data indicate that M. tuberculosis tRNA activates a gene network involving the integration of multiple innate signals, including types I and II IFNs, as well as distinct cell types to induce IL-12p70.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29610140      PMCID: PMC5916334          DOI: 10.4049/jimmunol.1701733

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  81 in total

1.  Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.

Authors:  T A Fehniger; M H Shah; M J Turner; J B VanDeusen; S P Whitman; M A Cooper; K Suzuki; M Wechser; F Goodsaid; M A Caligiuri
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

2.  IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12.

Authors:  S Matikainen; A Paananen; M Miettinen; M Kurimoto; T Timonen; I Julkunen; T Sareneva
Journal:  Eur J Immunol       Date:  2001-07       Impact factor: 5.532

3.  Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists.

Authors:  Kevin S Gorski; Emily L Waller; Jacqueline Bjornton-Severson; John A Hanten; Christie L Riter; William C Kieper; Keith B Gorden; Jeffrey S Miller; John P Vasilakos; Mark A Tomai; Sefik S Alkan
Journal:  Int Immunol       Date:  2006-05-25       Impact factor: 4.823

4.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

Review 5.  The balance between protective and pathogenic immune responses in the TB-infected lung.

Authors:  Ian M Orme; Richard T Robinson; Andrea M Cooper
Journal:  Nat Immunol       Date:  2015-01       Impact factor: 25.606

6.  APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA.

Authors:  Kerstin N Schmidt; Beatrice Leung; Mandy Kwong; Kol A Zarember; Sanjeev Satyal; Tony A Navas; Fay Wang; Paul J Godowski
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

7.  IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells.

Authors:  Roberto Lande; Elena Giacomini; Tiziana Grassi; Maria Elena Remoli; Elisabetta Iona; Minja Miettinen; Ilkka Julkunen; Eliana M Coccia
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

8.  Natural killer cells are recruited during pulmonary tuberculosis and their ex vivo responses to mycobacteria vary between healthy human donors in association with KIR haplotype.

Authors:  Damien Portevin; Laura E Via; Seokyong Eum; Douglas Young
Journal:  Cell Microbiol       Date:  2012-07-30       Impact factor: 3.715

9.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

10.  Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation.

Authors:  Xianqin Zhang; Dusan Bogunovic; Béatrice Payelle-Brogard; Véronique Francois-Newton; Scott D Speer; Chao Yuan; Stefano Volpi; Zhi Li; Ozden Sanal; Davood Mansouri; Ilhan Tezcan; Gillian I Rice; Chunyuan Chen; Nahal Mansouri; Seyed Alireza Mahdaviani; Yuval Itan; Bertrand Boisson; Satoshi Okada; Lu Zeng; Xing Wang; Hui Jiang; Wenqiang Liu; Tiantian Han; Delin Liu; Tao Ma; Bo Wang; Mugen Liu; Jing-Yu Liu; Qing K Wang; Dilek Yalnizoglu; Lilliana Radoshevich; Gilles Uzé; Philippe Gros; Flore Rozenberg; Shen-Ying Zhang; Emmanuelle Jouanguy; Jacinta Bustamante; Adolfo García-Sastre; Laurent Abel; Pierre Lebon; Luigi D Notarangelo; Yanick J Crow; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova; Sandra Pellegrini
Journal:  Nature       Date:  2014-10-12       Impact factor: 49.962

View more
  6 in total

1.  Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor.

Authors:  Douglas W Thomson; Daniel Poeckel; Nico Zinn; Christina Rau; Katrin Strohmer; Anne J Wagner; Alan P Graves; Jessica Perrin; Marcus Bantscheff; Birgit Duempelfeld; Viera Kasparcova; Joshi M Ramanjulu; G Scott Pesiridis; Marcel Muelbaier; Giovanna Bergamini
Journal:  ACS Med Chem Lett       Date:  2019-03-11       Impact factor: 4.345

Review 2.  Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment.

Authors:  Wen Li; Feifei Li; Xia Zhang; Hui-Kuan Lin; Chuan Xu
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

Review 3.  RNA Sensing of Mycobacterium tuberculosis and Its Impact on TB Vaccination Strategies.

Authors:  Sanne Burkert; Ralf R Schumann
Journal:  Vaccines (Basel)       Date:  2020-02-04

4.  Interaction of TLR4 and TLR8 in the Innate Immune Response against Mycobacterium Tuberculosis.

Authors:  Shruthi Thada; Gabor L Horvath; Mario M Müller; Nickel Dittrich; Melanie L Conrad; Saubashya Sur; Abid Hussain; Karin Pelka; Suman Latha Gaddam; Eicke Latz; Hortense Slevogt; Ralf R Schumann; Sanne Burkert
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

5.  The noncoding small RNA SsrA is released by Vibrio fischeri and modulates critical host responses.

Authors:  Silvia Moriano-Gutierrez; Clotilde Bongrand; Tara Essock-Burns; Leo Wu; Margaret J McFall-Ngai; Edward G Ruby
Journal:  PLoS Biol       Date:  2020-11-03       Impact factor: 8.029

Review 6.  Underwhelming or Misunderstood? Genetic Variability of Pattern Recognition Receptors in Immune Responses and Resistance to Mycobacterium tuberculosis.

Authors:  Jean-Yves Dubé; Vinicius M Fava; Erwin Schurr; Marcel A Behr
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.